Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

911-935 (Activation loop from InterPro)

Target domain

676-1042 (Catalytic domain of Class IA Phosphoinositide 3-kinase delta)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

15 structures for O00329

Entry ID Method Resolution Chain Position Source
5DXU X-ray 264 A A 2-1044 PDB
5M6U X-ray 285 A A 17-1027 PDB
5T8F X-ray 291 A A 17-1031 PDB
5UBT X-ray 283 A A 17-1029 PDB
5VLR X-ray 280 A A 17-1029 PDB
6G6W X-ray 272 A A 1-1044 PDB
6OCO X-ray 258 A A 17-1031 PDB
6OCU X-ray 277 A A 1-1044 PDB
6PYR X-ray 221 A A 17-1034 PDB
6PYU X-ray 254 A A 17-1034 PDB
7JIS X-ray 242 A A 17-1034 PDB
7LM2 X-ray 279 A A 12-1031 PDB
7LQ1 X-ray 296 A A 1-1044 PDB
8BCY X-ray 243 A A 17-1034 PDB
AF-O00329-F1 Predicted AlphaFoldDB

579 variants for O00329

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV001213350
CA338299362
rs1257745660
2 P>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV001318415
CA17769061
rs749032083
6 D>A Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001308996
CA576762
rs749032083
6 D>G Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001240756
rs1647002482
14 K>T Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
RCV000814653
rs765729544
CA576774
RCV002534844
38 R>C Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. Inborn genetic diseases [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV001213349
rs1647005150
41 N>H Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
CA576803
rs772851443
RCV001240551
52 R>H Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001237606
rs1043386158
CA17773325
74 N>S Immunodeficiency 14 Variant assessed as Somatic; impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
rs1553168726
RCV000651284
79 Q>missing Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
CA17773395
RCV001312599
rs768486795
87 R>W Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV001244034
rs765031777
RCV000788952
CA576828
108 R>L Immunodeficiency 14 Immunodeficiency 14 (imd14) [ClinVar, Ensembl] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA576834
rs756298807
RCV001296112
113 I>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs754053878
RCV001873219
CA576871
RCV000788936
133 D>N Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV001223726
rs1351397800
CA338300533
134 P>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001815405
rs142285826
CA576875
RCV001821612
RCV000550578
146 F>I Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs201492009
RCV000930378
CA576877
150 A>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA576881
RCV001326489
rs755788138
152 A>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000803781
rs148638384
CA576891
174 S>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA576896
rs767838052
RCV001055871
180 P>T Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs779715026
RCV000818088
CA576899
186 P>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA576903
RCV001351605
rs748146002
188 R>Q Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA576907
RCV000798222
rs569586715
194 V>I Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV001067875
rs1647371834
198 G>S Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
rs141200414
RCV000993900
RCV002501049
CA576909
RCV000795754
200 E>K Immunodeficiency 14 Combined immunodeficiency with faciooculoskeletal anomalies [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs781191290
RCV001231792
CA576944
212 V>M Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA338301102
rs1287665655
RCV003222212
RCV001059440
220 A>S Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV001507416
CA576952
RCV000816126
rs369430343
231 P>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000815078
rs1570363781
CA338301428
267 H>Y Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs1647584874
RCV001350694
270 L>W Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
rs1647586090
RCV001267781
273 H>Y Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
RCV000651285
RCV002252193
rs557471275
CA576999
285 M>T Immunodeficiency 14 Immunodeficiency 14 (imd14) [ClinVar, Ensembl] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1446283598
CA338301552
RCV000811172
287 D>H Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
rs969868296
RCV001345155
CA17776142
289 Q>R Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV001042544
CA338301599
rs765061150
293 A>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
COSM4144266
RCV001000392
RCV001811067
CA577006
rs28730668
296 V>I Immunodeficiency 14 thyroid [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs780386111
RCV001035657
CA577010
RCV003132148
300 R>H Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001810998
RCV000532966
rs61755420
CA577032
312 S>C Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs746649091
CA577034
RCV001044784
313 S>F Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA338301739
RCV000805494
rs770390674
314 V>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs758304879
RCV001212029
CA577037
322 P>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001090798
rs762697236
CA577040
RCV001362380
324 R>C Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs773473376
CA577042
RCV001055228
324 R>H Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs148703447
CA577043
RCV001056184
326 E>K Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV000701558
CA156204
RCV000119275
CA338301874
rs28730670
334 N>K Immunodeficiency 14 Immunodeficiency 14 (imd14) [ClinVar, Ensembl] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA577086
RCV001309658
rs775700162
357 T>M Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA577087
RCV001324399
rs763569477
358 V>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ExAC
gnomAD
ClinVar
dbSNP
CA577095
RCV001246948
COSM1178069
RCV001819952
rs143521812
370 V>M Immunodeficiency 14 prostate [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA17777699
RCV001068719
rs373591202
386 R>H Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
dbSNP
gnomAD
CA577108
RCV002534447
rs571644641
RCV000705870
RCV000788826
397 V>M Immunodeficiency 14 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs587777390
CA156210
RCV000119277
416 C>R Immunodeficiency 14 Variant assessed as Somatic; impact. Immunodeficiency 14 (imd14) [ClinVar, NCI-TCGA, Ensembl] Yes ClinGen
ClinVar
Ensembl
NCI-TCGA
dbSNP
rs755144547
RCV001223205
CA577141
424 M>T Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001503755
CA577147
rs28730673
437 R>C Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000706268
CA17779344
rs1035624064
440 Y>C Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001218514
CA577149
rs759238357
444 S>F Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
RCV000530768
CA577179
RCV001821611
rs28730674
456 T>A Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs373779625
RCV000651282
CA577184
460 R>H Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV000880920
CA577186
RCV002501381
rs368722127
465 T>M Immunodeficiency 14 Combined immunodeficiency with faciooculoskeletal anomalies [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1648292751
RCV001245905
478 V>M Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
rs1648293206
RCV001335226
479 A>T Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
rs201282174
RCV001760184
RCV001211124
COSM913592
CA577199
487 A>T Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. endometrium [ClinVar, NCI-TCGA, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV001342157
rs966409603
CA17779983
493 E>A Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
rs1342430054
CA338303612
RCV001299790
495 G>R Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV001231780
CA17780003
rs922490667
499 E>A Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs545136223
COSM48671
RCV000651288
CA577235
505 E>K lung Immunodeficiency 14 large_intestine haematopoietic_and_lymphoid_tissue [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV000788579
RCV001580541
CA338303813
rs1557669079
RCV000706607
525 E>G Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA156207
rs587777389
RCV000119276
525 E>K Immunodeficiency 14 Immunodeficiency 14 (imd14) [ClinVar, Ensembl] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA338303952
RCV001304597
rs1220175470
545 A>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA577276
RCV002252292
RCV001226681
RCV000993901
COSM180412
rs780269932
548 R>W Immunodeficiency 14 large_intestine [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ExAC
dbSNP
gnomAD
RCV001224666
rs1648521215
558 H>R Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
CA338304140
RCV000806632
rs1302155596
570 S>F Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA338304152
RCV000986231
rs1570385564
572 P>S Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001440865
rs199549932
CA577314
RCV000942902
576 V>I Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001047400
rs893249484
CA17780647
592 V>I Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs143068130
RCV000486578
CA577321
RCV000651286
593 G>R Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000698101
CA577326
rs138090835
601 R>Q Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001338840
rs1648646851
616 V>M Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
rs993552815
CA17780912
RCV001299105
622 E>K Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001225845
CA577358
rs769421641
631 K>R Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000792456
CA338304968
rs1481047336
692 L>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA577438
rs751020974
RCV002562401
RCV001214039
699 V>I Immunodeficiency 14 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
VAR_085590 721 Q>del ROCHIS; no protein can be detected by Western blot in patient cells [UniProt] Yes UniProt
RCV000792866
rs765640030
CA577451
723 A>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs376114835
RCV001220339
CA577455
732 Q>E Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001233734
CA577459
rs547875116
RCV003130207
736 D>N Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs755934302
CA577460
RCV000651283
738 S>R Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001050184
rs745896452
CA577485
766 E>K Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs200226248
CA577487
RCV002534467
RCV000706674
771 G>S Immunodeficiency 14 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000651296
rs149376192
CA577490
RCV001815425
772 G>S Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs370932461
CA577492
RCV000821949
774 V>M Immunodeficiency 14 Variant assessed as Somatic; 9.63e-05 impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA338305795
RCV001317384
rs1247300105
788 M>I Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV001262333
rs1648958091
819 G>R Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
rs756497515
COSM1239842
CA577559
RCV001348958
830 R>H Immunodeficiency 14 Variant assessed as Somatic; 0.0001386 impact. pancreas oesophagus [ClinVar, NCI-TCGA, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ExAC
NCI-TCGA
dbSNP
gnomAD
RCV001338836
rs1648966090
835 A>T Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
RCV001315772
CA17782869
rs200369205
844 M>L Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA577570
RCV001066516
COSM913597
rs148984508
864 P>L Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. endometrium [ClinVar, NCI-TCGA, Cosmic] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
NCI-TCGA
dbSNP
gnomAD
RCV001303381
rs1371422939
867 A>S Immunodeficiency 14 [ClinVar] Yes ClinVar
dbSNP
RCV000548743
rs1553171728
CA338307772
900 M>V Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs757964104
RCV001326116
CA577635
944 Q>E Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001048863
rs758647199
CA577667
957 R>W Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA577670
rs142907633
RCV001507418
RCV000949868
958 G>D Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs975282953
RCV001067678
COSM1185301
CA17785215
983 A>V lung Immunodeficiency 14 Variant assessed as Somatic; impact. [Cosmic, ClinVar, NCI-TCGA] Yes ClinGen
cosmic curated
ClinVar
Ensembl
NCI-TCGA
dbSNP
RCV000799093
CA577723
rs142050444
RCV000414322
1010 E>A Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA145460
RCV003224135
rs397518423
RCV000507954
RCV001027610
COSM1581454
VAR_070918
RCV000076908
RCV000224521
1021 E>K Immunodeficiency 14 Variant assessed as Somatic; 0.0 impact. Combined immunodeficiency with faciooculoskeletal anomalies haematopoietic_and_lymphoid_tissue Inherited Immunodeficiency Diseases Immunodeficiency 14 (imd14) IMD14A; results in gain of function causing enhanced membrane association and kinase activity [ClinVar, NCI-TCGA, Cosmic, Ensembl, UniProt] Yes ClinGen
cosmic curated
ClinVar
UniProt
NCI-TCGA
dbSNP
gnomAD
CA17787141
RCV001204006
rs759704849
RCV002249791
1024 R>H Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs1064795762
RCV000479211
CA16617216
RCV001227774
1025 E>G Immunodeficiency 14 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs541082914
CA576757
2 P>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs750425882
CA576759
3 P>A No ClinGen
ExAC
gnomAD
TCGA novel 3 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA576761
rs780051553
3 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA576760
rs750425882
3 P>S No ClinGen
ExAC
gnomAD
CA338299382
CA17769072
rs1037340766
6 D>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
TOPMed
gnomAD
NCI-TCGA
rs879660382
CA17769059
6 D>N No ClinGen
Ensembl
CA576763
rs772424669
7 C>R No ClinGen
ExAC
TOPMed
gnomAD
rs867168019
CA17769102
10 E>D No ClinGen
gnomAD
rs200039969
CA576765
10 E>K No ClinGen
1000Genomes
ExAC
gnomAD
rs1185347441
CA338299476
19 S>G No ClinGen
TOPMed
CA338299480
rs376606452
19 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM172990
CA576768
rs143116020
20 V>I ovary Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA576769
rs770275584
21 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs775849617
CA576770
22 V>I No ClinGen
ExAC
gnomAD
rs1382575108
CA338299541
30 V>I No ClinGen
gnomAD
rs763687876
CA576773
31 Y>F No ClinGen
ExAC
CA17769127
rs1046472589
32 L>V No ClinGen
Ensembl
CA338299579
rs1279930246
35 P>R No ClinGen
TOPMed
gnomAD
rs761349863
COSM1220603
CA576775
38 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs761349863
CA338299594
38 R>P No ClinGen
ExAC
gnomAD
rs1223183330
CA338299613
41 N>T No ClinGen
gnomAD
rs1570356518
CA338299820
51 H>P No ClinGen
Ensembl
rs1375117381
CA338299832
52 R>C No ClinGen
TOPMed
rs766440014
COSM1345053
CA576805
53 A>T Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs576937504
CA576806
55 Y>F No ClinGen
1000Genomes
ExAC
gnomAD
rs1057524823
RCV000418140
CA16603713
61 M>V No ClinGen
ClinVar
Ensembl
dbSNP
CA576812
rs757517500
67 A>T No ClinGen
ExAC
gnomAD
rs1570356775
CA338300072
71 T>P No ClinGen
Ensembl
rs745980735
CA576814
73 I>V No ClinGen
ExAC
gnomAD
CA338300144
rs1570356857
77 A>V No ClinGen
Ensembl
CA338300157
rs1557659457
79 Q>R No ClinGen
Ensembl
rs1253851300
CA338300170
81 E>Q No ClinGen
gnomAD
rs377713059
CA576816
83 E>Q No ClinGen
ESP
ExAC
gnomAD
CA338300214
rs1557659523
87 R>Q No ClinGen
Ensembl
COSM1220601
CA338300219
rs1557659540
88 R>C large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
rs769029561
CA576818
88 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA338300217
rs1557659540
88 R>S No ClinGen
Ensembl
rs775052663
CA576819
90 C>* No ClinGen
ExAC
gnomAD
rs1167794081
CA338300278
97 P>S No ClinGen
TOPMed
rs150205370
CA576823
98 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 100 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs766022415
CA576825
100 R>L No ClinGen
ExAC
gnomAD
rs1229729609
CA338300308
103 A>T No ClinGen
gnomAD
CA338300316
rs1315288471
104 R>C No ClinGen
TOPMed
gnomAD
CA338300317
rs776273008
104 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA576826
rs776273008
104 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs1225852287
CA338300330
106 G>D No ClinGen
gnomAD
CA576827
COSM1636756
rs759579609
107 D>N bone [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs1205317546
CA338300341
108 R>C No ClinGen
gnomAD
CA576829
rs765031777
108 R>H Immunodeficiency 14 (imd14) [Ensembl] No ClinGen
ExAC
TOPMed
gnomAD
rs767750196
CA576831
109 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs1449263530
CA338300349
110 K>Q No ClinGen
gnomAD
rs201273776
CA338300383
114 N>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA576835
rs780165100
114 N>S No ClinGen
ExAC
gnomAD
rs1198914856
CA338300415
119 L>F No ClinGen
TOPMed
rs1026915695
CA17774382
122 G>S No ClinGen
TOPMed
gnomAD
CA338300465
rs1410662789
125 L>F No ClinGen
TOPMed
gnomAD
CA338300463
rs1410662789
125 L>I No ClinGen
TOPMed
gnomAD
rs1366821546
CA338300510
131 L>S No ClinGen
TOPMed
rs1308861733
CA338300514
132 C>S No ClinGen
TOPMed
CA338300575
rs1405541611
140 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA576873
rs765297753
141 A>S No ClinGen
ExAC
gnomAD
CA338300579
rs765297753
141 A>T No ClinGen
ExAC
gnomAD
CA338300583
COSM682612
rs1265306349
141 A>V lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs752804924
CA576874
143 M>V No ClinGen
ExAC
gnomAD
CA338300605
rs1226611327
144 C>F No ClinGen
gnomAD
CA576876
rs778360032
148 E>K No ClinGen
ExAC
gnomAD
CA338300656
rs1490939727
151 A>V No ClinGen
gnomAD
rs138463758
COSM913583
CA576880
152 A>T Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs779489980
CA576882
153 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs748728424
CA576883
153 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs779489980
CA338300661
153 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA576885
rs774223814
154 R>Q No ClinGen
ExAC
TOPMed
gnomAD
RCV000788692
CA338300666
rs1557660486
154 R>W No ClinGen
ClinVar
Ensembl
dbSNP
rs1415749883
CA338300683
156 Q>H No ClinGen
gnomAD
rs1425025065
CA338300691
158 G>S No ClinGen
gnomAD
CA338300699
RCV000993899
rs1570358964
159 W>* No ClinGen
ClinVar
Ensembl
dbSNP
rs1299852654
CA338300706
160 E>K No ClinGen
TOPMed
CA338300737
rs1557660567
164 Q>R No ClinGen
Ensembl
rs1570359037
CA338300756
166 S>R No ClinGen
Ensembl
TCGA novel 169 L>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM1220602
rs759732725
CA338300777
170 Q>* large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA576889
rs759732725
170 Q>K No ClinGen
ExAC
gnomAD
CA338300792
rs1373757791
172 E>G No ClinGen
TOPMed
rs529803273
CA576890
173 P>H No ClinGen
1000Genomes
ExAC
gnomAD
CA17774852
rs377020532
175 A>V No ClinGen
ESP
TOPMed
gnomAD
rs757809265
CA576895
178 W>R No ClinGen
ExAC
TOPMed
gnomAD
CA576897
rs547988333
181 G>S No ClinGen
1000Genomes
ExAC
gnomAD
CA576898
rs755725121
184 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1250682190
CA338300861
184 R>W No ClinGen
TOPMed
gnomAD
CA576902
rs754531708
188 R>G No ClinGen
ExAC
gnomAD
CA576901
rs754531708
188 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA576904
rs772030591
189 A>G No ClinGen
ExAC
gnomAD
CA338300901
rs1180364983
192 V>I No ClinGen
gnomAD
CA576905
rs772893560
193 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs757878191
CA576940
201 E>D No ClinGen
ExAC
gnomAD
rs1201485090
CA338300986
202 S>N No ClinGen
gnomAD
CA338301021
rs1158740935
207 V>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA576942
rs751559889
209 T>A No ClinGen
ExAC
gnomAD
rs866528417
CA17775379
211 D>N No ClinGen
Ensembl
CA576947
rs779226622
215 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1458892485
CA338301109
221 L>V No ClinGen
TOPMed
CA338301114
rs1216060233
222 R>Q No ClinGen
gnomAD
rs772233114
CA576949
222 R>W No ClinGen
ExAC
gnomAD
rs1199039488
CA338301144
226 T>I No ClinGen
TOPMed
CA338301161
rs1224681360
229 R>Q No ClinGen
gnomAD
CA576951
rs761298080
229 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs369430343
CA17775437
231 P>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA338301184
rs1421176893
233 V>A No ClinGen
gnomAD
CA338301185
rs1421176893
233 V>G No ClinGen
gnomAD
CA338301180
rs1406071172
233 V>M No ClinGen
gnomAD
CA338301190
rs1570361652
234 E>G No ClinGen
Ensembl
CA576954
rs759852203
235 Q>K No ClinGen
ExAC
gnomAD
CA576955
rs373049250
236 P>L No ClinGen
ESP
ExAC
gnomAD
rs1366683993
CA338301210
237 E>G No ClinGen
gnomAD
CA576957
rs762485999
240 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA576960
rs751020278
244 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs750264393
CA576962
245 G>A No ClinGen
ExAC
gnomAD
CA338301262
rs201035266
245 G>R No ClinGen
1000Genomes
ExAC
gnomAD
CA576961
rs201035266
245 G>S No ClinGen
1000Genomes
ExAC
gnomAD
rs756020651
CA576963
246 R>K No ClinGen
ExAC
gnomAD
rs779682634
CA576964
246 R>S No ClinGen
ExAC
gnomAD
CA338301271
rs1570361862
247 H>D No ClinGen
Ensembl
CA576965
rs748470223
254 Y>F No ClinGen
ExAC
CA17775594
rs964552978
258 Q>K No ClinGen
TOPMed
gnomAD
rs796730337
CA17776047
262 I>V No ClinGen
TOPMed
CA576992
rs775936372
267 H>R No ClinGen
ExAC
gnomAD
rs1457927140
CA338301434
268 S>G No ClinGen
TOPMed
CA576993
rs749549630
269 G>R No ClinGen
ExAC
gnomAD
CA17776080
rs1005945340
278 H>R No ClinGen
TOPMed
CA338301501
rs1405126587
278 H>Y No ClinGen
TOPMed
CA576995
rs773827938
280 S>F No ClinGen
ExAC
gnomAD
CA576997
rs767202630
284 A>T No ClinGen
ExAC
gnomAD
CA576998
rs772834969
285 M>L No ClinGen
ExAC
gnomAD
rs146796121
COSM465142
CA17776138
286 R>W kidney [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs917453045
CA17776141
288 E>K No ClinGen
TOPMed
gnomAD
CA577004
rs765061150
293 A>D No ClinGen
ExAC
gnomAD
rs759200030
CA577003
293 A>T No ClinGen
ExAC
CA338301600
rs1345563055
294 P>S No ClinGen
TOPMed
gnomAD
rs575048807
CA577005
295 Q>H No ClinGen
1000Genomes
ExAC
gnomAD
rs754116182 295 Q>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1200911257
CA338301618
296 V>G No ClinGen
gnomAD
CA338301633
rs1570364376
298 K>N No ClinGen
Ensembl
rs201869776
CA577007
299 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1445282622
CA338301642
300 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA338301649
rs1350137252
301 A>G No ClinGen
gnomAD
rs1483926787
CA338301670
304 P>L No ClinGen
Ensembl
rs1483926787
CA338301669
304 P>R No ClinGen
Ensembl
rs749687214
CA577011
COSM1345056
308 A>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA338301725
rs1386854832
311 P>S No ClinGen
gnomAD
rs746649091
CA338301738
313 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs1395915862
CA338301735
313 S>P No ClinGen
gnomAD
TCGA novel 314 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA577035
rs770390674
314 V>M No ClinGen
ExAC
gnomAD
CA338301770
rs1452381525
319 L>V No ClinGen
gnomAD
CA577041
rs762697236
324 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA338301808
rs1557663489
325 I>V No ClinGen
Ensembl
CA338301829
rs1570366466
328 I>L No ClinGen
Ensembl
TCGA novel 328 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs369790602
CA17776652
CA338301839
329 Q>H No ClinGen
ESP
TOPMed
rs766425588
CA577044
329 Q>R No ClinGen
ExAC
gnomAD
rs373890620
CA577048
335 A>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA577047
rs765798990
335 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA338301875
rs765798990
335 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA17776694
rs760642664
336 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1469537812
CA338301894
338 R>G No ClinGen
gnomAD
CA577052
rs145191685
338 R>Q No ClinGen
ESP
ExAC
gnomAD
CA338301937
rs1570371332
342 V>G No ClinGen
Ensembl
COSM913588
rs1423364986
CA338301952
345 A>T Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1350006292
CA338301960
346 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA577081
rs747930872
350 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA577084
rs759798937
352 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs188586233
CA577088
358 V>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA338302056
rs1481780395
360 S>N No ClinGen
gnomAD
CA338302063
rs1179481484
361 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1179481484
CA338302064
361 S>W No ClinGen
gnomAD
CA17777595
rs1054834456
363 V>A No ClinGen
Ensembl
CA577089
rs774630166
364 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs147079051
CA577090
365 V>M No ClinGen
ESP
ExAC
gnomAD
CA577091
rs375873391
367 S>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs143521812
CA577096
370 V>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 371 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA577097
rs370509251
374 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1403673258
CA338302160
376 E>D No ClinGen
gnomAD
CA577098
rs748011804
376 E>G No ClinGen
ExAC
gnomAD
rs771940649
CA577099
377 F>V No ClinGen
ExAC
gnomAD
CA338302169
rs1453300166
378 D>N No ClinGen
TOPMed
CA17777682
rs866028543
380 N>S No ClinGen
TOPMed
gnomAD
CA338302187
rs866028543
380 N>T No ClinGen
TOPMed
gnomAD
rs149331749
CA17777690
RCV000658489
383 D>N No ClinGen
ClinVar
ESP
dbSNP
gnomAD
CA338302246
rs1454291091
389 R>C No ClinGen
TOPMed
rs1460280596
CA338302247
389 R>H No ClinGen
gnomAD
CA17777716
rs1048477125
393 A>V No ClinGen
TOPMed
gnomAD
rs774975013
CA577106
396 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1426700543
COSM94989
CA338302298
397 V>A lung [Cosmic] No ClinGen
cosmic curated
gnomAD
CA338302306
rs760322402
398 I>M No ClinGen
ExAC
gnomAD
CA577111
rs765972601
399 E>K No ClinGen
ExAC
gnomAD
rs1249840890
CA338302318
400 K>R No ClinGen
gnomAD
rs1648004459
RCV001090799
405 R>C No ClinVar
dbSNP
CA338302353
rs1219279866
405 R>H No ClinGen
gnomAD
CA17777897
rs907101954
407 T>A No ClinGen
TOPMed
CA338302371
rs1337423492
408 K>R No ClinGen
TOPMed
CA338302412
rs1273460827
413 K>N No ClinGen
TOPMed
rs1214315014
CA338302418
414 A>V No ClinGen
TOPMed
gnomAD
TCGA novel 416 C>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA577138
rs139648797
418 I>V No ClinGen
ESP
ExAC
gnomAD
rs1335325896
CA338302525
428 Y>C No ClinGen
gnomAD
CA338302566
rs1378083934
433 K>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA577144
rs772651596
434 T>I No ClinGen
ExAC
gnomAD
rs1570377463
CA338302568
434 T>P No ClinGen
Ensembl
rs747483450
CA577146
436 E>K No ClinGen
ExAC
gnomAD
rs776965614
CA577148
437 R>H Variant assessed as Somatic; 0.0004619 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA17779342
rs878878305
440 Y>H No ClinGen
Ensembl
CA17779348
rs868416824
442 W>* No ClinGen
Ensembl
rs1238600891
CA338302635
444 S>A No ClinGen
gnomAD
CA577152
rs762320758
445 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA338302676
rs1301530593
448 E>D No ClinGen
gnomAD
CA338302670
rs1469618469
448 E>Q No ClinGen
gnomAD
CA577178
rs147088845
451 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA577180
rs751570218
456 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA17779503
COSM107815
rs147135836
457 G>S skin [Cosmic] No ClinGen
cosmic curated
Ensembl
CA577182
rs781504902
459 V>M No ClinGen
ExAC
gnomAD
CA577183
rs746363298
460 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA577185
rs780466125
464 N>S No ClinGen
ExAC
gnomAD
CA338302793
rs1570378665
467 S>N No ClinGen
Ensembl
CA577189
rs761356083
468 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1397404017
CA338302802
469 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs866568855
CA17779542
472 L>F No ClinGen
Ensembl
rs867227561
CA17779545
472 L>P No ClinGen
Ensembl
CA338302828
rs1175788378
473 I>M No ClinGen
TOPMed
rs929800121
CA17779548
476 P>S No ClinGen
TOPMed
gnomAD
CA577192
rs572367173
477 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA577193
rs766145180
480 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA338302868
rs1158507595
480 P>S No ClinGen
gnomAD
CA338302876
rs1344295424
481 H>R No ClinGen
gnomAD
rs763164485
CA577195
481 H>Y No ClinGen
ExAC
gnomAD
rs751662332
CA577197
483 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA338302927
rs1570378984
485 Y>S No ClinGen
Ensembl
rs201282174
CA338302942
487 A>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA338302954
rs1258900023
488 L>V No ClinGen
TOPMed
gnomAD
rs756635161
CA577201
489 E>K No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 490 K>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1400888893
CA338303615
495 G>E No ClinGen
gnomAD
rs761958757
CA577232
496 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA338303637
rs1221225492
498 S>R No ClinGen
gnomAD
rs767714303
CA577233
499 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA338303646
rs1237485949
500 C>G No ClinGen
gnomAD
CA17780006
rs148463269
500 C>Y No ClinGen
1000Genomes
gnomAD
rs999028906
CA17780013
501 V>M No ClinGen
TOPMed
gnomAD
CA17780024
rs957609763
502 H>R No ClinGen
Ensembl
CA338303695
rs1260887969
507 E>G No ClinGen
TOPMed
CA338303694
rs1260887969
507 E>V No ClinGen
TOPMed
CA17780183
rs1043871084
509 L>V No ClinGen
TOPMed
CA577259
rs753025128
512 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs765797019
CA577258
512 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA17780217
rs866391453
514 I>V No ClinGen
Ensembl
rs1441813233
CA338303766
517 R>Q No ClinGen
gnomAD
rs991423011
CA17780242
517 R>W No ClinGen
gnomAD
CA338303771
rs1235829952
518 R>Q No ClinGen
gnomAD
rs1185305370
CA338303770
518 R>W Variant assessed as Somatic; 0.0001424 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA577261
rs201274224
520 S>A No ClinGen
ExAC
gnomAD
CA577262
rs751294374
521 G>V No ClinGen
ExAC
TOPMed
gnomAD
rs756847877
CA577263
522 E>G No ClinGen
ExAC
gnomAD
CA338303790
rs1423112466
522 E>K No ClinGen
gnomAD
CA338303825
rs749871179
527 E>K No ClinGen
ExAC
gnomAD
CA577265
rs749871179
527 E>Q No ClinGen
ExAC
gnomAD
CA338303844
rs1332713912
529 D>E No ClinGen
TOPMed
gnomAD
CA17780278
rs915886106
529 D>H No ClinGen
TOPMed
CA17780274
rs915886106
529 D>N No ClinGen
TOPMed
CA577266
rs756081093
530 L>V No ClinGen
ExAC
gnomAD
rs1277009277
CA338303852
531 V>L No ClinGen
gnomAD
rs1182302845
CA338303879
535 R>Q No ClinGen
gnomAD
rs768558857
CA577269
535 R>W No ClinGen
ExAC
gnomAD
CA338303886
rs1198694875
536 H>R No ClinGen
TOPMed
gnomAD
CA338303895
rs1444212968
537 E>D No ClinGen
gnomAD
rs778557081
CA577270
537 E>K No ClinGen
ExAC
gnomAD
CA577271
rs747265210
539 Q>* No ClinGen
ExAC
gnomAD
CA338303912
rs1262560788
540 E>Q No ClinGen
gnomAD
rs759640288
CA577274
545 A>T No ClinGen
ExAC
gnomAD
CA338303967
rs1297091785
548 R>Q No ClinGen
gnomAD
CA338304016
rs1257526121
556 N>S No ClinGen
gnomAD
CA338304036
rs1215767354
559 E>K No ClinGen
gnomAD
CA338304065
rs1285460528
563 Q>E No ClinGen
gnomAD
rs1487319918
CA338304072
563 Q>H No ClinGen
TOPMed
gnomAD
CA577306
rs752658744
564 M>L No ClinGen
ExAC
gnomAD
CA338304086
rs752658744
564 M>V No ClinGen
ExAC
gnomAD
rs576655113
CA577307
565 L>F No ClinGen
1000Genomes
ExAC
gnomAD
CA577308
rs777706880
566 Y>C No ClinGen
ExAC
TOPMed
gnomAD
COSM1345064
CA577310
rs756348630
572 P>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs774421473
CA577312
573 E>D No ClinGen
ExAC
gnomAD
rs924608773
CA17780607
573 E>G No ClinGen
Ensembl
CA338304175
rs1175850851
576 V>A No ClinGen
TOPMed
CA338304190
rs1255847906
579 A>T No ClinGen
TOPMed
gnomAD
rs371700599
CA577319
589 D>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs371700599
CA17780645
589 D>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA338304276
rs1287071221
591 H>R No ClinGen
TOPMed
CA577320
rs776226369
592 V>A Immunodeficiency 14 (imd14) [Ensembl] No ClinGen
ExAC
gnomAD
rs752748467
CA577323
598 K>Q No ClinGen
ExAC
gnomAD
rs369950232
CA17780667
599 S>L No ClinGen
ESP
TOPMed
gnomAD
CA577325
rs763994711
601 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs754072203
CA577329
604 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs1379547883
CA338304376
606 D>N No ClinGen
TOPMed
gnomAD
rs1156998927
CA338304402
609 F>L No ClinGen
gnomAD
rs1410207038
CA338304405
610 Q>* No ClinGen
gnomAD
rs755166062
CA577349
610 Q>H No ClinGen
ExAC
gnomAD
rs1245822943
CA338304449
617 Q>* No ClinGen
TOPMed
rs1570387413
CA338304459
618 V>G No ClinGen
Ensembl
rs1219775997
CA338304456
618 V>M No ClinGen
gnomAD
rs747518017
CA577354
622 E>A No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 624 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA338304495
rs1202012732
624 Y>N No ClinGen
TOPMed
CA577355
rs771265754
624 Y>S No ClinGen
ExAC
gnomAD
CA338304523
rs1287221059
628 E>K No ClinGen
TOPMed
gnomAD
CA577360
rs748760424
636 R>Q Variant assessed as Somatic; 4.624e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs868613820
CA17780963
639 A>T No ClinGen
Ensembl
CA577361
rs768262076
641 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs768262076
CA577362
641 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA577363
rs761809287
641 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA17780993
rs971647866
644 G>S No ClinGen
Ensembl
CA577364
rs767226031
647 L>V No ClinGen
ExAC
gnomAD
rs1557670901
CA338304652
648 F>C No ClinGen
Ensembl
rs1570387790
CA338304667
650 H>P No ClinGen
Ensembl
CA17781033
rs1002736660
651 L>P No ClinGen
Ensembl
rs765392990
CA577367
652 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA338304678
rs765392990
652 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA338304715
rs1211872659
655 M>I No ClinGen
TOPMed
gnomAD
rs756589761
CA577394
657 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA17781301
rs906973167
658 P>A No ClinGen
TOPMed
gnomAD
CA577395
rs780565270
658 P>L Immunodeficiency 14 (imd14) [Ensembl] No ClinGen
ExAC
gnomAD
rs780565270
CA338304733
658 P>Q Immunodeficiency 14 (imd14) [Ensembl] No ClinGen
ExAC
gnomAD
CA338304731
rs906973167
658 P>T No ClinGen
TOPMed
gnomAD
rs754606582
CA577397
659 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs754606582
CA338304739
659 S>W No ClinGen
ExAC
TOPMed
gnomAD
CA577399
rs747642494
660 V>L No ClinGen
ExAC
gnomAD
CA338304745
rs1358312295
661 A>T No ClinGen
gnomAD
rs370028348
CA577401
663 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs746943903
CA577402
663 R>H No ClinGen
ExAC
gnomAD
rs369126260
CA17781369
665 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
NCI-TCGA
rs763166445
CA338304785
667 I>M No ClinGen
ExAC
gnomAD
rs1235191543
CA338304804
670 A>V No ClinGen
gnomAD
rs768827923
CA577406
671 Y>D No ClinGen
ExAC
gnomAD
rs1135424
CA17781421
675 S>R No ClinGen
Ensembl
rs1192325470
CA338304897
683 M>I No ClinGen
gnomAD
CA338304890
rs1557671578
683 M>L No ClinGen
Ensembl
rs760029461
CA577433
686 G>E No ClinGen
ExAC
gnomAD
rs1195446780
CA338304970
692 L>P No ClinGen
TOPMed
CA577434
rs765509045
693 K>N No ClinGen
ExAC
rs370548772
COSM3419609
CA577437
698 F>L large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA338305013
rs751020974
699 V>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 701 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA338305034
rs1481897966
702 S>N No ClinGen
gnomAD
TCGA novel 704 Q>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs150236912
CA577440
706 T>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA577441
rs745781507
707 P>S No ClinGen
ExAC
gnomAD
CA17781638
rs745781507
707 P>T No ClinGen
ExAC
gnomAD
rs779707145
CA577443
708 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1477333023
CA338305080
709 P>L No ClinGen
TOPMed
gnomAD
CA577446
rs773461308
711 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1570390604
CA338305107
713 E>V No ClinGen
Ensembl
rs1374880877
CA338305148
718 C>W No ClinGen
gnomAD
CA338305154
rs1295281515
719 M>I No ClinGen
gnomAD
CA577449
rs777338647
719 M>L No ClinGen
ExAC
gnomAD
CA17781684
rs964373496
720 R>Q No ClinGen
TOPMed
rs1336890715
CA338305158
720 R>W No ClinGen
TOPMed
rs1570390774
CA338305174
722 E>G No ClinGen
Ensembl
CA338305181
rs765640030
723 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA577452
rs143471703
725 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs762689558
CA338305206
727 A>G No ClinGen
ExAC
gnomAD
rs762689558
CA577453
727 A>V No ClinGen
ExAC
gnomAD
CA17781703
rs948347302
730 H>Y No ClinGen
Ensembl
CA338305252
rs1184606534
735 L>F No ClinGen
gnomAD
CA338305258
rs1175223977
736 D>A No ClinGen
gnomAD
CA338305262
rs1557672296
736 D>E No ClinGen
Ensembl
rs963136903
CA17781729
739 T>P No ClinGen
Ensembl
rs1314823847
CA338305282
740 L>M No ClinGen
gnomAD
TCGA novel 740 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1430239142
CA338305295
742 A>G No ClinGen
gnomAD
TCGA novel 744 V>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1557672535
CA338305347
748 Q>* No ClinGen
Ensembl
rs1557672549
CA338305358
749 C>S No ClinGen
Ensembl
rs751837497
CA577482
753 D>N No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 753 D>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 757 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA17781898
rs972860101
765 N>K No ClinGen
TOPMed
gnomAD
rs1457681300
CA338305484
766 E>A No ClinGen
gnomAD
rs1457681300
CA338305485
766 E>G No ClinGen
gnomAD
rs749787380
CA338305518
771 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA577488
rs749787380
771 G>V No ClinGen
ExAC
TOPMed
gnomAD
CA338305537
rs1570392143
774 V>G No ClinGen
Ensembl
RCV000599055
rs1553171177
777 I>missing No ClinVar
dbSNP
rs1648809005
RCV001261782
781 G>R No ClinVar
dbSNP
CA338305745
rs1486776204
785 R>Q No ClinGen
gnomAD
rs1372847864
CA338305800
789 L>V No ClinGen
gnomAD
rs1310527452
CA338305879
795 Q>* No ClinGen
gnomAD
rs1570393363
CA338305892
RCV000788624
797 M>V No ClinGen
ClinVar
Ensembl
dbSNP
CA577532
rs778136495
799 V>I No ClinGen
ExAC
gnomAD
TCGA novel 806 L>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA338305970
rs1324429905
807 D>E No ClinGen
gnomAD
CA338305968
rs1570393434
807 D>G No ClinGen
Ensembl
rs768809863
CA17782805
811 T>S No ClinGen
Ensembl
rs781451534
CA17782811
812 P>L No ClinGen
TOPMed
CA577552
rs757531779
814 G>S No ClinGen
ExAC
gnomAD
rs1433204550
CA338306059
818 T>N No ClinGen
gnomAD
TCGA novel 820 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM1503840
CA577555
rs140820694
821 R>C lung [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs573872848
CA577556
COSM913596
821 R>H Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA577558
rs768587227
822 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs1570395770
CA338306163
827 V>G No ClinGen
Ensembl
rs554743340
CA17782819
830 R>C No ClinGen
TOPMed
gnomAD
TCGA novel 836 N>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 838 Q>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1397536891
CA338306312
840 N>K No ClinGen
TOPMed
rs1334243610
CA338306350
843 N>S No ClinGen
gnomAD
rs759690872
CA577563
844 M>R No ClinGen
ExAC
gnomAD
CA577564
rs77080134
845 A>P No ClinGen
ExAC
gnomAD
CA577566
rs763402967
849 A>T No ClinGen
ExAC
gnomAD
CA338306473
rs1194777620
853 D>G No ClinGen
gnomAD
rs201426574 864 P>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA577569
rs148984508
864 P>R No ClinGen
1000Genomes
ExAC
gnomAD
CA577588
rs768006265
866 E>D No ClinGen
ExAC
gnomAD
CA338307547
rs1427870699
866 E>K No ClinGen
gnomAD
rs1430108390
CA338307551
866 E>V No ClinGen
TOPMed
rs1371422939
CA338307554
867 A>P No ClinGen
gnomAD
rs1371422939
CA338307553
867 A>T No ClinGen
gnomAD
rs750767155
CA577589
869 D>G No ClinGen
ExAC
gnomAD
TCGA novel 869 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA17784431
rs752328071
870 R>Q No ClinGen
TOPMed
rs1304989504
CA338307627
878 S>Y No ClinGen
gnomAD
rs1401643921
CA338307654
882 Y>C No ClinGen
TOPMed
CA17784446
rs75568188
883 C>F No ClinGen
Ensembl
TCGA novel 893 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs771951762
CA577596
894 R>Q No ClinGen
ExAC
gnomAD
rs202142608
CA17784497
902 R>Q No ClinGen
1000Genomes
TOPMed
gnomAD
CA338307793
rs1237870323
903 E>Q No ClinGen
gnomAD
COSM355917
rs770690790
CA577599
905 G>V lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs749536854
CA577623
910 I>V No ClinGen
ExAC
TOPMed
gnomAD
RCV000993903
CA338307865
rs1570400255
911 D>G No ClinGen
ClinVar
Ensembl
dbSNP
CA338307978
rs1570400328
927 R>C No ClinGen
Ensembl
CA577628
rs773911101
929 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs761256209
CA577629
935 T>I No ClinGen
ExAC
CA17784858
rs145589432
937 D>N No ClinGen
Ensembl
TCGA novel 941 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 945 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1223914240
CA338308113
947 T>A No ClinGen
gnomAD
CA577637
rs751502057
954 E>A No ClinGen
ExAC
gnomAD
CA338308174
rs1414657892
955 R>W No ClinGen
gnomAD
rs201362243
CA17785144
957 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA577668
rs201362243
957 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA577669
rs755117692
958 G>C No ClinGen
ExAC
TOPMed
gnomAD
rs746383662
CA577672
962 R>S No ClinGen
ExAC
gnomAD
TCGA novel 964 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1570402517
CA338308250
965 T>P No ClinGen
Ensembl
CA577676
rs768257375
968 R>W No ClinGen
ExAC
gnomAD
rs551657853
CA577677
969 R>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA577678
rs761274254
969 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA577680
rs750392184
971 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA338308316
rs1570402731
976 H>P No ClinGen
Ensembl
CA338308340
rs1420482705
979 A>V No ClinGen
gnomAD
CA17785214
rs964857770
982 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA577685
rs778194087
982 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1457464907
CA338308447
996 Q>* No ClinGen
gnomAD
CA17785228
rs983734803
996 Q>R No ClinGen
Ensembl
rs759480750
CA577720
1006 K>R No ClinGen
ExAC
gnomAD
rs765139386
CA577721
1007 T>R No ClinGen
ExAC
gnomAD
CA17787054
rs764181256
1008 E>* No ClinGen
Ensembl
TCGA novel 1009 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1649753771
RCV001090800
1016 R>* No ClinVar
dbSNP
CA577725
rs750587940
1016 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA338308833
rs1293688309
1019 F>L No ClinGen
TOPMed
COSM682606
rs1384520389
CA338308863
1024 R>C lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA17787163
rs56042861
1031 V>A No ClinGen
Ensembl
CA17787171
rs201414602
1032 N>D No ClinGen
1000Genomes
CA338309007
rs1214099696
1044 Q>R No ClinGen
TOPMed

3 associated diseases with O00329

[MIM: 615513]: Immunodeficiency 14A, autosomal dominant (IMD14A)

A disorder characterized by recurrent respiratory infections, progressive airway damage, lymphopenia, increased circulating transitional B cells, increased immunoglobulin M, reduced immunoglobulin G2 levels in serum, and impaired vaccine responses. {ECO:0000269|PubMed:24136356}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 619281]: Immunodeficiency 14B, autosomal recessive (IMD14B)

An autosomal recessive, primary immunodeficiency characterized by recurrent sinopulmonary infections apparent in early childhood. Some patients may develop inflammatory bowel disease or osteomyelitis. Immunological features include hypogammaglobulinemia, decreased levels of B cells, and evidence of impaired immune-mediated cytotoxicity and defective T-cell function. {ECO:0000269|PubMed:30040974, ECO:0000269|PubMed:30336224}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 613328]: Roifman-Chitayat syndrome (ROCHIS)

An autosomal recessive digenic disorder characterized by global developmental delay, variable neurologic features such as seizures and ataxia, optic atrophy, dysmorphic facial features, distal skeletal anomalies, and recurrent invasive infections due to combined immunodeficiency. {ECO:0000269|PubMed:29180244}. Note=The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry. Caused by the simultaneous occurrence of homozygous mutations in PIK3CD and KNSTRN. {ECO:0000269|PubMed:29180244}.

Without disease ID
  • A disorder characterized by recurrent respiratory infections, progressive airway damage, lymphopenia, increased circulating transitional B cells, increased immunoglobulin M, reduced immunoglobulin G2 levels in serum, and impaired vaccine responses. {ECO:0000269|PubMed:24136356}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • An autosomal recessive, primary immunodeficiency characterized by recurrent sinopulmonary infections apparent in early childhood. Some patients may develop inflammatory bowel disease or osteomyelitis. Immunological features include hypogammaglobulinemia, decreased levels of B cells, and evidence of impaired immune-mediated cytotoxicity and defective T-cell function. {ECO:0000269|PubMed:30040974, ECO:0000269|PubMed:30336224}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • An autosomal recessive digenic disorder characterized by global developmental delay, variable neurologic features such as seizures and ataxia, optic atrophy, dysmorphic facial features, distal skeletal anomalies, and recurrent invasive infections due to combined immunodeficiency. {ECO:0000269|PubMed:29180244}. Note=The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry. Caused by the simultaneous occurrence of homozygous mutations in PIK3CD and KNSTRN. {ECO:0000269|PubMed:29180244}.

8 regional properties for O00329

Type Name Position InterPro Accession
domain Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain 175 - 281 IPR000341
domain Phosphatidylinositol 3-/4-kinase, catalytic domain 745 - 1041 IPR000403
domain Phosphoinositide 3-kinase, accessory (PIK) domain 497 - 685 IPR001263
domain C2 phosphatidylinositol 3-kinase-type domain 309 - 476 IPR002420
domain Phosphatidylinositol 3-kinase, adaptor-binding domain 16 - 108 IPR003113
conserved_site Phosphatidylinositol 3/4-kinase, conserved site 778 - 792 IPR018936-1
conserved_site Phosphatidylinositol 3/4-kinase, conserved site 878 - 898 IPR018936-2
domain PI3Kdelta, catalytic domain 676 - 1042 IPR037703

Functions

Description
EC Number 2.7.1.137 Phosphotransferases with an alcohol group as acceptor
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
phosphatidylinositol 3-kinase complex A protein complex capable of phosphatidylinositol 3-kinase activity and containing subunits of any phosphatidylinositol 3-kinase (PI3K) enzyme. These complexes are divided in three classes (called I, II and III) that differ for their presence across taxonomic groups and for the type of their constituents. Catalytic subunits of phosphatidylinositol 3-kinase enzymes are present in all 3 classes; regulatory subunits of phosphatidylinositol 3-kinase enzymes are present in classes I and III; adaptor proteins have been observed in class II complexes and may be present in other classes too.
phosphatidylinositol 3-kinase complex, class IA A class I phosphatidylinositol 3-kinase complex that possesses 1-phosphatidylinositol-4-phosphate 3-kinase activity; comprises a catalytic class IA phosphoinositide 3-kinase (PI3K) subunit and an associated SH2 domain-containing regulatory subunit that is a member of a family of related proteins often called p85 proteins. Through the interaction with the SH2-containing adaptor subunits, Class IA PI3K catalytic subunits are linked to tyrosine kinase signaling pathways.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

8 GO annotations of molecular function

Name Definition
1-phosphatidylinositol-3-kinase activity Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
1-phosphatidylinositol-4-phosphate 3-kinase activity Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4-phosphate + ATP = 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + ADP + 2 H(+).
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
kinase activity Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
phosphatidylinositol 3-kinase activity Catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol 3-phosphate. This reaction is the addition of a phosphate group to phosphatidylinositol or one of its phosphorylated derivatives at the 3' position of the inositol ring.
phosphatidylinositol kinase activity Catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate.
phosphatidylinositol-3,4-bisphosphate 5-kinase activity Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
phosphatidylinositol-4,5-bisphosphate 3-kinase activity Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).

39 GO annotations of biological process

Name Definition
adaptive immune response An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
B cell activation The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
B cell chemotaxis The directed movement of a B cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
B cell differentiation The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
B cell receptor signaling pathway The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell.
cell migration The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
immune response Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
inflammatory response The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
innate immune response Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
mast cell chemotaxis The movement of a mast cell in response to an external stimulus.
mast cell degranulation The regulated exocytosis of secretory granules containing preformed mediators such as histamine, serotonin, and neutral proteases by a mast cell.
mast cell differentiation The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a mast cell. A mast cell is a cell that is found in almost all tissues containing numerous basophilic granules and capable of releasing large amounts of histamine and heparin upon activation.
natural killer cell activation The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor.
natural killer cell chemotaxis The directed movement of a natural killer cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
natural killer cell differentiation The process in which a relatively unspecialized cell acquires the specialized features of a natural killer cell.
neutrophil chemotaxis The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
neutrophil extravasation The migration of a neutrophil from the blood vessels into the surrounding tissue.
phosphatidylinositol 3-kinase signaling A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions.
phosphatidylinositol phosphate biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylinositol phosphate.
phosphatidylinositol-3-phosphate biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
phosphatidylinositol-mediated signaling The series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
positive regulation of angiogenesis Any process that activates or increases angiogenesis.
positive regulation of cell migration Any process that activates or increases the frequency, rate or extent of cell migration.
positive regulation of cell migration by vascular endothelial growth factor signaling pathway The series of molecular signals initiated by vascular endothelial growth factor (VEGF) binding to its receptor on the surface of a cell, which activates or increases the frequency, rate or extent of the orderly movement of a cell from one site to another.
positive regulation of cytokine production Any process that activates or increases the frequency, rate or extent of production of a cytokine.
positive regulation of endothelial cell migration Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
positive regulation of endothelial cell proliferation Any process that activates or increases the rate or extent of endothelial cell proliferation.
positive regulation of epithelial tube formation Any process that activates or increases the frequency, rate or extent of epithelial tube formation.
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
positive regulation of neutrophil apoptotic process Any process that activates or increases the frequency, rate, or extent of neutrophil apoptotic process.
positive regulation of protein kinase B signaling Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
protein phosphorylation The process of introducing a phosphate group on to a protein.
respiratory burst involved in defense response A phase of elevated metabolic activity, during which oxygen consumption increases made as part of a defense response ; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
T cell activation The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
T cell chemotaxis The directed movement of a T cell in response to an external stimulus. A T cell is a type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.
T cell differentiation The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
T cell receptor signaling pathway The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.

14 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P32871 PIK3CA Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Bos taurus (Bovine) PR
Q9UBF8 PI4KB Phosphatidylinositol 4-kinase beta Homo sapiens (Human) PR
P42356 PI4KA Phosphatidylinositol 4-kinase alpha Homo sapiens (Human) PR
O00443 PIK3C2A Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha Homo sapiens (Human) PR
P48736 PIK3CG Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (Human) PR
P42336 PIK3CA Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Homo sapiens (Human) PR
P42338 PIK3CB Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Homo sapiens (Human) PR
P42337 Pik3ca Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Mus musculus (Mouse) PR
Q8BTI9 Pik3cb Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Mus musculus (Mouse) PR
Q9JHG7 Pik3cg Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Mus musculus (Mouse) PR
O35904 Pik3cd Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform Mus musculus (Mouse) PR
O02697 PIK3CG Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Sus scrofa (Pig) PR
Q9Z1L0 Pik3cb Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform Rattus norvegicus (Rat) PR
Q94125 age-1 Phosphatidylinositol 3-kinase age-1 Caenorhabditis elegans PR
10 20 30 40 50 60
MPPGVDCPME FWTKEENQSV VVDFLLPTGV YLNFPVSRNA NLSTIKQLLW HRAQYEPLFH
70 80 90 100 110 120
MLSGPEAYVF TCINQTAEQQ ELEDEQRRLC DVQPFLPVLR LVAREGDRVK KLINSQISLL
130 140 150 160 170 180
IGKGLHEFDS LCDPEVNDFR AKMCQFCEEA AARRQQLGWE AWLQYSFPLQ LEPSAQTWGP
190 200 210 220 230 240
GTLRLPNRAL LVNVKFEGSE ESFTFQVSTK DVPLALMACA LRKKATVFRQ PLVEQPEDYT
250 260 270 280 290 300
LQVNGRHEYL YGSYPLCQFQ YICSCLHSGL TPHLTMVHSS SILAMRDEQS NPAPQVQKPR
310 320 330 340 350 360
AKPPPIPAKK PSSVSLWSLE QPFRIELIQG SKVNADERMK LVVQAGLFHG NEMLCKTVSS
370 380 390 400 410 420
SEVSVCSEPV WKQRLEFDIN ICDLPRMARL CFALYAVIEK AKKARSTKKK SKKADCPIAW
430 440 450 460 470 480
ANLMLFDYKD QLKTGERCLY MWPSVPDEKG ELLNPTGTVR SNPNTDSAAA LLICLPEVAP
490 500 510 520 530 540
HPVYYPALEK ILELGRHSEC VHVTEEEQLQ LREILERRGS GELYEHEKDL VWKLRHEVQE
550 560 570 580 590 600
HFPEALARLL LVTKWNKHED VAQMLYLLCS WPELPVLSAL ELLDFSFPDC HVGSFAIKSL
610 620 630 640 650 660
RKLTDDELFQ YLLQLVQVLK YESYLDCELT KFLLDRALAN RKIGHFLFWH LRSEMHVPSV
670 680 690 700 710 720
ALRFGLILEA YCRGSTHHMK VLMKQGEALS KLKALNDFVK LSSQKTPKPQ TKELMHLCMR
730 740 750 760 770 780
QEAYLEALSH LQSPLDPSTL LAEVCVEQCT FMDSKMKPLW IMYSNEEAGS GGSVGIIFKN
790 800 810 820 830 840
GDDLRQDMLT LQMIQLMDVL WKQEGLDLRM TPYGCLPTGD RTGLIEVVLR SDTIANIQLN
850 860 870 880 890 900
KSNMAATAAF NKDALLNWLK SKNPGEALDR AIEEFTLSCA GYCVATYVLG IGDRHSDNIM
910 920 930 940 950 960
IRESGQLFHI DFGHFLGNFK TKFGINRERV PFILTYDFVH VIQQGKTNNS EKFERFRGYC
970 980 990 1000 1010 1020
ERAYTILRRH GLLFLHLFAL MRAAGLPELS CSKDIQYLKD SLALGKTEEE ALKHFRVKFN
1030 1040
EALRESWKTK VNWLAHNVSK DNRQ